About: alpha-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • The so-called mitocans from the vitamin E group of selective anticancer drugs, α-tocopheryl succinate (α-TOS) and its ether analogue α-TEA, triggered apoptosis in proliferating but not arrested endothelial cells. Angiogenic endothelial cells exposed to the vitamin E analogues, unlike their arrested counterparts, readily accumulated ROS by interfering with the mitochondrial redox chain and activating the intrinsic apoptotic pathway. The vitamin E analogues inhibited angiogenesis in vitro as assessed using the „wound-healing“ and „tube-forming“ models. Endothelial cells deficient in mitochondrial DNA were resistant to the vitamin E analogues, both in ROS accumulation and apoptosis induction, maintaining their high angiogenic potential. α-TOS inhibited angiogenesis in a mouse cancer model, as documented by ultrasound imaging. We conclude that vitamin E analogues selectively kill angiogenic endothelial cells, suppressing tumor growth, which has intriguing clinical implications.
  • The so-called mitocans from the vitamin E group of selective anticancer drugs, α-tocopheryl succinate (α-TOS) and its ether analogue α-TEA, triggered apoptosis in proliferating but not arrested endothelial cells. Angiogenic endothelial cells exposed to the vitamin E analogues, unlike their arrested counterparts, readily accumulated ROS by interfering with the mitochondrial redox chain and activating the intrinsic apoptotic pathway. The vitamin E analogues inhibited angiogenesis in vitro as assessed using the „wound-healing“ and „tube-forming“ models. Endothelial cells deficient in mitochondrial DNA were resistant to the vitamin E analogues, both in ROS accumulation and apoptosis induction, maintaining their high angiogenic potential. α-TOS inhibited angiogenesis in a mouse cancer model, as documented by ultrasound imaging. We conclude that vitamin E analogues selectively kill angiogenic endothelial cells, suppressing tumor growth, which has intriguing clinical implications. (en)
  • Tzv. mitokany α-TOS a jeho etherový analog α-TEA jako selektivní protirakovinné látky ze skupiny vitaminu E spouštěly apoptózu v proliferujících, nikoliv v nedělících se endoteliálních buňkách. Angiogenní endoteliální buňky vystavené analogům vitaminu E snadno akumulovaly ROS zasahováním do mitochondriálních redoxních řetězců a aktivovaly vnitřní apoptotické dráhy, na rozdíl od neproliferujích protějšků. Analogy vitaminu E inhibovaly angiogenezu in vitro, jak bylo stanoveno na modelech „hojení ran“ a „tvoření trubiček“. Endoteliální buňky deficientní v mitochondriální DNA byly rezistentní k analogům vitaminu E, jak při stanovení akumulace ROS tak při stanovení indukce apoptózy, a udržovaly tak svůj vysoký angiogenní potenciál. α-TOS inhiboval angiogenezu v modelu myší rakoviny, což bylo dokumentováno zobrazením ultrazvukem. Uzavíráme, že analogy vitaminu E selektivně zabíjely angiogenní endoteliální buňky a potlačovaly růst nádorů, což má důležité klinické implikace. (cs)
Title
  • alpha-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling
  • alfa-Tokoferylsukcinát inhibuje angiogenezu přerušením parakrinních FGF2- signálních drah (cs)
  • alpha-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling (en)
skos:prefLabel
  • alpha-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling
  • alfa-Tokoferylsukcinát inhibuje angiogenezu přerušením parakrinních FGF2- signálních drah (cs)
  • alpha-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling (en)
skos:notation
  • RIV/68378050:_____/07:00096529!RIV08-AV0-68378050
http://linked.open.../vavai/riv/strany
  • 4611;4615
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • Z(AV0Z50520514), Z(AV0Z50520701)
http://linked.open...iv/cisloPeriodika
  • 24
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 409117
http://linked.open...ai/riv/idVysledku
  • RIV/68378050:_____/07:00096529
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • mitocans; proliferating endothelial cells; apoptosis (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [2D2513CE8FC5]
http://linked.open...i/riv/nazevZdroje
  • FEBS Letters
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 581
http://linked.open...iv/tvurceVysledku
  • Neužil, Jiří
  • Dong, L. F.
  • Stapelberg, M.
  • Swettenham, E.
  • Wang, X. F.
http://linked.open...n/vavai/riv/zamer
issn
  • 0014-5793
number of pages
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software